Zdrowie i gospodarka · 04/08/2025
FDA Clears Heparin Sodium Products for Approval of Abbreviated New Drug Applications
The FDA has determined that three Heparin Sodium products were not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications for these products.